103 related articles for article (PubMed ID: 3193767)
1. Amplification of the c-myc proto-oncogene in cervical carcinoma.
Baker VV; Hatch KD; Shingleton HM
J Surg Oncol; 1988 Dec; 39(4):225-8. PubMed ID: 3193767
[TBL] [Abstract][Full Text] [Related]
2. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the structure and expression of the c-myc oncogene in cervical tumor and in cervical tumor-derived cell lines.
Choo KB; Chong KY; Chou HF; Liew LN; Liou CC
Biochem Biophys Res Commun; 1989 Jan; 158(1):334-40. PubMed ID: 2463837
[TBL] [Abstract][Full Text] [Related]
4. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
[TBL] [Abstract][Full Text] [Related]
5. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
Tanimoto H; Nagai N; Fujimoto H; Ohta S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):566-70. PubMed ID: 1619315
[TBL] [Abstract][Full Text] [Related]
6. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
[TBL] [Abstract][Full Text] [Related]
7. HER-2/neu gene amplification in cervical cancer in Chinese women of Hong Kong and China.
Wong YF; Chung TK; Cheung TH; Lam SK; Tam OS; Lu HJ; Xu FD; Chang AM
J Obstet Gynaecol Res; 1996 Apr; 22(2):171-5. PubMed ID: 8697348
[TBL] [Abstract][Full Text] [Related]
8. The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.
Riou GF; Bourhis J; Le MG
Anticancer Res; 1990; 10(5A):1225-31. PubMed ID: 2173473
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
[TBL] [Abstract][Full Text] [Related]
10. c-myc gene amplification detected in preinvasive intraepithelial cervical lesions.
Golijow CD; Abba MC; Mourón SA; Gómez MA; Dulout FN
Int J Gynecol Cancer; 2001; 11(6):462-5. PubMed ID: 11906549
[TBL] [Abstract][Full Text] [Related]
11. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
Riou G; Barrois M; Lê MG; George M; Le Doussal V; Haie C
Lancet; 1987 Apr; 1(8536):761-3. PubMed ID: 2882179
[TBL] [Abstract][Full Text] [Related]
12. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
Gutman M; Ravia Y; Assaf D; Yamamoto T; Rozin R; Shiloh Y
Int J Cancer; 1989 Nov; 44(5):802-5. PubMed ID: 2573579
[TBL] [Abstract][Full Text] [Related]
13. DNA aneuploidy in invasive carcinoma of the uterine cervix.
Kashyap V; Bhambhani S
Indian J Pathol Microbiol; 2000 Jul; 43(3):265-9. PubMed ID: 11218670
[TBL] [Abstract][Full Text] [Related]
14. Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
Leonard JH; Kearsley JH; Chenevix-Trench G; Hayward NK
Int J Cancer; 1991 Jun; 48(4):511-5. PubMed ID: 2045198
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers.
Riou G; Lê MG; Favre M; Jeannel D; Bourhis J; Orth G
J Natl Cancer Inst; 1992 Oct; 84(19):1525-6. PubMed ID: 1331478
[No Abstract] [Full Text] [Related]
16. [Carcinogenic mechanisms of multiple genes in cervical carcinoma].
Huang G; Xiao X; Huang Y; Huang R
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):5-9. PubMed ID: 9208611
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of S-phase fraction as measured by DNA flow cytometry in gynecologic malignancies.
Strang P; Stendahl U; Tribukait B
Ann N Y Acad Sci; 1993 Mar; 677():354-63. PubMed ID: 8494220
[No Abstract] [Full Text] [Related]
18. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix.
Bourhis J; Le MG; Barrois M; Gerbaulet A; Jeannel D; Duvillard P; Le Doussal V; Chassagne D; Riou G
J Clin Oncol; 1990 Nov; 8(11):1789-96. PubMed ID: 2230867
[TBL] [Abstract][Full Text] [Related]
20. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
